InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ODN 1826 - TLR9 ligand | Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopoly... | 2024 | Immunohorizons | Ting K.K.Y. et al. | DOI: 10.4049/immunohorizons.2300101 |
| LPS-EB (LPS from E. coli O111:B4) | Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopoly... | 2024 | Immunohorizons | Ting K.K.Y. et al. | DOI: 10.4049/immunohorizons.2300101 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Phospholipids impact the protective effects of HDL-mimetic nanodiscs against ... | 2023 | Nanomedicine (Lond). | Kim S.Y. et al. | DOI: 10.2217/nnm-2023-0222 |
| Plasmocin® - Mycoplasma Elimination Reagent | The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo M... | 2024 | Cancer Res Commun. | Mazar J. et al. | DOI: 10.1158/2767-9764.CRC-23-0221 |
| A549-Dual™ Cells | TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... | 2024 | Antiviral Res. | Govednik T. et al. | DOI: 10.1016/j.antiviral.2024.105806 |
| Zeocin® | TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... | 2024 | Antiviral Res. | Govednik T. et al. | DOI: 10.1016/j.antiviral.2024.105806 |
| Blasticidin | TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... | 2024 | Antiviral Res. | Govednik T. et al. | DOI: 10.1016/j.antiviral.2024.105806 |
| QUANTI-Blue™ | TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... | 2024 | Antiviral Res. | Govednik T. et al. | DOI: 10.1016/j.antiviral.2024.105806 |
| Poly(I:C) HMW | TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower infl... | 2024 | Antiviral Res. | Govednik T. et al. | DOI: 10.1016/j.antiviral.2024.105806 |
| Blasticidin | Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma ... | 2024 | J Cell Mol Med. | Yun H. et al. | DOI: 10.1111/jcmm.18104 |
| Primocin® | How do deer respiratory epithelial cells weather the initial storm of SARS-Co... | 2024 | Microbiol Spectr. | Sarlo Davila K.M. et al. | DOI: 10.1128/spectrum.02524-23 |
| THP1-Dual™ Cells | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| ODN 2006 (ODN 7909) | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| ODN 2216 - TLR9 ligand | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| LL-37 | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| Pam3CSK4 | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| MDP | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| LPS-EK (LPS from E. coli K12) | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| QUANTI-Blue™ | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |
| QUANTI-Luc™: Luciferase Detection Reagent | Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activ... | 2024 | Nat Chem Biol. | Chiu T.Y. et al. | DOI: 10.1038/s41589-023-01527-8 |